Abstract Ion channels in smooth muscle control coronary vascular tone, but the identity of the potassium channels involved requires further investigation. The purpose of this study was to evaluate the functional role of K V 1 channels on porcine coronary blood flow using the selective antagonist correolide. K V 1 channel gene transcripts were found in porcine coronary arteries, with KCNA5 (encoding K V 1.5) being most abundant (P \ 0.001). Immunohistochemical staining demonstrated K V 1.5 protein in the vascular smooth muscle layer of both porcine and human coronary arteries, including microvessels. Whole-cell patch-clamp experiments demonstrated significant correolide-sensitive (1-10 lM) current in coronary smooth muscle. In vivo studies included direct intracoronary infusion of vehicle or correolide into a pressure-clamped left anterior descending artery of healthy swine (n = 5 in each group) with simultaneous measurement of coronary blood flow. Intracoronary correolide (*0.3-3 lM targeted plasma concentration) had no effect on heart rate or systemic pressure, but reduced coronary blood flow in a dosedependent manner (P \ 0.05). Dobutamine (0.3-10 lg/kg/ min) elicited coronary metabolic vasodilation and intracoronary correolide (3 lM) significantly reduced coronary blood flow at any given level of myocardial oxygen consumption (P \ 0.001). Coronary artery occlusions (15 s) elicited reactive hyperemia and correolide (3 lM) reduced the flow volume repayment by approximately 30 % (P \ 0.05). Taken together, these data support a major role for K V 1 channels in modulating baseline coronary vascular tone and, perhaps, vasodilation in response to increased metabolism and transient ischemia.
Introduction
The limited anaerobic capacity and oxygen extraction reserve of the heart render the myocardium highly dependent on a continuous supply of oxygen to maintain normal cardiac function. The ability of the coronary circulation to provide adequate perfusion may be challenged by a variety of physiologic factors that modulate microvascular resistance and balance oxygen delivery with the underlying myocardial requirements. A number of regulatory mechanisms participate in the control of coronary blood flow [7] , many of which may be affected by disease [37] . Despite decades of research, understanding of the mechanisms responsible for the regulation of coronary blood flow remains incomplete and there are currently more hypotheses than accepted pathways [8] .
Significant evidence supports the idea that K ? channels function as critical downstream effectors, on which multiple signaling pathways converge to modulate coronary vasomotor tone [27] . Although multiple types of K baseline coronary blood flow and inhibits local metabolic and ischemic vasodilation [3, 4, 9] . The precise K V channel subtypes involved have not, however, been clearly defined. Given emerging data regarding the role of H 2 O 2 in endothelial and metabolic coronary vasodilation [16, 22, 36] , recent studies have focused on redox-sensitive K V channels with varying conclusions. While data do not support a prominent role for K V 7 channels in coronary metabolic dilation of rodents or swine [15, 23] , genetic deletion of K V 1.5 channels was found to significantly inhibit the tight coupling of coronary blood flow to myocardial metabolism in mice [31] . These findings support an evolving paradigm, in which K V 1 channels play requisite roles in controlling coronary blood flow responses to physiological and pathophysiological stimuli.
This study tested the hypothesis that K V 1 channels are functionally expressed in coronary smooth muscle and regulate coronary vascular tone at rest, in response to increases in myocardial metabolism, and following transient ischemic episodes (reactive hyperemia). We used swine as experimental models and performed quantitative polymerase chain reaction (qPCR) to investigate the expression of KCNA genes and immunohistochemistry to determine the presence of K V 1 channel protein in coronary vascular smooth muscle. The contribution of K V 1 channels to outward K ? current in isolated coronary smooth muscle cells was assessed by patch-clamp electrophysiology with correolide, a selective K V 1 channel inhibitor (1-10 lM). The role of K V 1 channels in regulating coronary vascular resistance in vivo was examined with intracoronary administration of correolide (10 swine were divided into two groups; 5 received vehicle only, while 5 were treated with correolide). We determined the effects of correolide on: (a) resting coronary blood flow (infused directly into the coronary artery to reach 0.3-3 lM in the plasma); (b) metabolic dilation evoked by dobutamine challenge (0.3-10 lg/kg/min); and (c) ischemic dilation in response to a 15 s coronary artery occlusion (reactive hyperemia). Correolide has been tested against more than 100 ion channels and receptors; it blocks all members of the K V 1 family, but has no known inhibitory effects on other targets [12, 18, 21] . Unique effects of correolide on K V 1 channels are due to the presence of a conserved, high specificitybinding site in the S5 and S6 segments of these channels [17] . 
Methods

qPCR analysis of KCNA expression
The left anterior descending (LAD) coronary artery was dissected from the heart and cleaned of adipose and connective tissue. Total RNA was isolated using the RNeasy fibrous tissue kit (QIAGEN) and stored at -80°C. cDNA synthesis was performed using 1 lg of total RNA and the iScript cDNA synthesis kit (Bio-Rad). qRT-PCR was performed using SYBR Green Supermix (Bio-Rad). The specificity of PCR amplification products was validated by the melting-curve analysis. KCNA and GAPDH (glyceraldehyde 3-phosphate dehydrogenase) primers were designed using the Premier Primer 5 software (PREMIER Biosoft). Primer sequences and amplicon sizes are given in Table 1 . KCNA gene expression was normalized to GAPDH and analyzed with the Bio-Rad CFX Manager software.
K V 1.5 immunohistochemical staining, immunofluorescent localization, and immunoblot
These experiments were performed using an antibody with established reactivity against K V 1.5 in both swine and humans (APC-150; Alomone Labs; [3] ). For the conventional immunohistochemistry, formalin-fixed, paraffin-embedded sections of swine and human coronary arteries were stained in conjunction with the Indiana University Immunohistochemistry Laboratory Core (Indiana University Health, Department of Pathology). A separate section of human coronary artery was additionally exposed to appropriate isotype control to demonstrate specificity of the primary antibody. Slides were imaged on an inverted microscope (model 3032, Accu-Scope Inc.) and images captured with a digital camera and associated software (DMC2900 and LAS V4.6, Leica Microsystems).
Immunofluorescent staining of the swine coronary microvasculature was performed on myocardial samples. Tissue was fixed in 4 % paraformaldehyde for 2 h on ice, washed in phosphate buffered saline, and frozen in TissueTek O.C.T. Compound (Sakura Finete) on a bed of dry ice and isopentane. Cryosections (8 lm) were cut and O.C.T. was removed by a 5 min wash in Tris buffered saline (TBS). Tissues were permeabilized in 0.2 % Triton X-100 in TBS for 5 min, washed, and blocked in 5 % horse serum in TBS at room temperature for 1 h. Sections were incubated at 37°with the K V 1.5 antibody (1:200) and an antismooth muscle actin antibody conjugated to Cy3 (1:250; C1698, Sigma). Sections without the K V 1.5 primary antibody served as a negative control. To further verify specificity of the K V 1.5 immunoreactivity, some sections were incubated with anti-K V 1.5 and blocking peptide (i.e., control antigen; *1 lg of peptide/lg of antibody). K V 1.5 immunoreactivity was detected with anti-rabbit Alexa Fluor 647 (1:4000; Jackson ImmunoResearch). Slides were mounted in ProLong Gold with DAPI (Invitrogen) and visualized by confocal microscopy (Olympus Fluoview FV1000).
Western blots with the K V 1.5 antibody were performed on lysates prepared from coronary arteries. Arterial segments were homogenized in lysis and extraction buffercontaining (mM) 50 b-glycerophosphate, 0.1 Na 3 VO 4 , 2 MgCl 2 , 1 EGTA, 1 DTT, 0.02 pepstatin, 0.02 leupeptin, and 1 PMSF, as well as 0.5 % Triton X-100 and 0.1 U/ml aprotinin. Lysate (100 lg of protein by Bradford assay; Bio-Rad) was loaded on a 4-12 % Bis-Tris gel (Life Technologies) and electrophoresed. Protein was transferred to nitrocellulose membranes overnight at 4°C and then blocked 1 h at room temperature with 5 % bovine serum albumin. Membranes were incubated in primary antibody (1:200) at 4°C overnight. Membranes were washed and placed for 1 h at room temperature in horseradish peroxidase-linked secondary antibody (1:2000 of goat anti-rabbit; Santa Cruz Biotechnology). K V 1.5 immunoreactivity was visualized with ECL Prime (Amersham).
Patch-clamp electrophysiology
Segments of the swine LAD were enzymatically digested to isolate coronary smooth muscle as previously described [9] . Currents were measured at room temperature in the conventional dialyzed patches. The bath solution contained 
Surgical preparation
Adult male domestic swine (n = 10) were sedated with telazol, xylazine, and ketamine (5, 2.5, and 2.5 mg/kg, s.c.) prior to anesthesia with morphine (3 mg/kg, i.m.) and a-chloralose (100 mg/kg, i.v.). Once a surgical plane of anesthesia was established, pigs were intubated and ventilated with O 2 -supplemented room air. Catheters were placed into the thoracic aorta via the right femoral artery (for blood pressure and heart rate monitoring), into the left femoral artery (to draw a supply of blood for the extracorporeal perfusion system), and into the right femoral vein (for supplemental anesthetic, heparin, and sodium bicarbonate). The heart was accessed via thoracotomy, so that the LAD could be isolated and cannulated. The animal was heparinized (500 U/kg, iv) and acute in vivo experiments were conducted using an extracorporeal pressure-clamped perfusion system. Coronary perfusion pressure was maintained at 100 mmHg by a servo-controlled peristaltic pump throughout the study and blood flow was continuously measured by an in-line flow transducer (Transonic Systems). A catheter was inserted into the interventricular coronary vein to allow sampling of venous blood from the LAD perfusion territory. Blood gas parameters were kept within normal physiologic limits through periodic blood gas analyses and appropriate adjustments to breathing rate, tidal volume, and/or bicarbonate supplementation. Data were continuously recorded using the IOX data acquisition software (EMKA Technologies).
Experimental protocol
Following coronary cannulation, hemodynamic variables were allowed to stabilize for 15-30 min before initiation of the protocol. Swine were then randomly assigned to the correolide-treated or vehicle only group (n = 5 each). Three different protocols were performed to examine the role of K V 1 channels in the control of coronary blood flow. (1) To examine the capacity of K V 1 channels to modulate coronary vascular resistance at rest, vehicle (DMSO diluted to 10 %) or correolide (in 10 % DMSO) was continuously infused into the coronary perfusion circuit via a syringe pump. To obtain the target plasma concentrations of correolide (0.3-3 lM), pump infusion rates were calculated based on hematocrit and coronary blood flow. (2) The contribution of K V 1 channels to metabolic coronary vasodilation was assessed with infusion of dobutamine (0.3-10 lg/kg/min, iv) with or without intracoronary correolide (3 lM in coronary plasma). (3) The role of K V 1 channels in ischemic coronary vasodilation was investigated by occluding the coronary perfusion circuit for 15 s and then measuring reactive hyperemia with or without intracoronary infusion of correolide (3 lM in coronary plasma). Hemodynamic measurements were continuously acquired and analyzed when variables stabilized (e.g., 3-5 min after an intravenous administration of dobutamine).
Statistical analyses
Data are expressed as mean ± standard error for a given number of swine or smooth muscle cells. Statistical comparisons were made with t tests and one-or two-way analysis of variance (ANOVA) as appropriate. In all statistical tests, P \ 0.05 was considered statistically significant. When significance was detected with ANOVA, a Student-Newman-Keuls multiple comparison test was performed to identify differences between groups and treatment levels. Data regarding the effects of correolide on the balance between coronary blood flow and myocardial metabolism were analyzed by linear regression and analysis of covariance (ANCOVA). Volume payment of reactive hyperemia was calculated as area under the curve using the Prism software (GraphPad Inc.).
Results
PCR analysis of KCNA expression in coronary arteries
KCNA genes (KNCA1…KCNA10) encode K V 1 channels (K V 1.1…K V 1.8). We performed qPCR analyses to establish the relative abundance of KCNA transcripts in coronary arteries from swine (n = 3; Fig. 1 ). Primer sequences are provided in Table 1 . KCNA expression was normalized to a reference gene, GAPDH. We detected the expression of all eight known KCNA gene transcripts, with KCNA5 being most abundant (KCNA5 expression was significantly higher than all other KCNA transcripts). KCNA2 was also expressed prominently (KCNA2 expression was significantly higher than all other KCNA transcripts, except for KCNA5). The abundance of all other KCNA genes was lower and statistically indistinguishable (no statistically significant differences between the levels of KCNA1, KCNA3, KCNA4, KCNA6, KCNA7, or KCNA10).
Immunohistochemical detection K V 1.5 protein in coronary arteries, including resistance-sized microvessels
Building on the observation that KCNA5 was the most abundant of all K V 1 transcripts in epicardial coronary samples, we assessed coronary artery expression of K V 1.5 protein with immunohistochemical techniques. This analysis was performed using a commercially available Fig. 2c) . Moreover, we confirmed that this antibody has appropriate reactivity in swine using the Western blot techniques (Fig. 2d) , as done previously [3] . Since regulation of coronary blood flow is largely controlled by vessels with diameters less than 200 lm, we further examined the localization of K V 1.5 protein in myocardial sections containing resistance-sized microvessels (Fig. 3) . Sections of swine myocardium were treated with antibodies against K V 1.5 and smooth muscle actin (SMA), as well as a nuclear stain. Immunoreactivity of the antibodies was detected by fluorescence in separate color channels (red and green). Overlaying the color images revealed prominent K V 1.5 immunoreactivity in SMA-positive microvessels (Fig. 3a-c) . Pre-adsorbing the K V 1.5 antibody with the antigenic peptide eliminated the detection of K V 1.5 immunoreactivity in SMA-positive microvessels ( Fig. 3d-f ). These data indicate that K V 1.5 channels are expressed in vessels of a caliber appropriate for regulating coronary vascular resistance. chelator and ATP to the pipette solution). Under these conditions, the K V or delayed rectifier K ? current was prominent (i.e., there was time-and voltage-dependent current that saturated at positive potentials [14, 39] ). Correolide inhibited K V current in smooth muscle cells from the porcine coronary artery in a concentration-dependent manner (Fig. 4) , indicating that K V 1 subunits likely comprise a major portion of the channels active under these conditions. Current in the presence of 1 lM correolide was reduced [30 % at voltages between ?20 and ?100 mV (P \ 0.05; Fig. 4c ; n = 4). Current in the presence of 10 lM correolide was reduced [80 % at voltages between -20 and ?100 mV (P \ 0.05; Fig. 4f ; n = 5).
K V 1 channels regulate coronary blood flow at the resting heart rate Our first in vivo experiment was to determine the effect of correolide on coronary blood flow at the resting heart rate. Concentration-response experiments showing the effects of direct intracoronary infusion of correolide (to targeted plasma concentrations between 0.3 and 3 lM; n = 5 correolide-treated swine) are in Fig. 5 . Correolide is completely insoluble in water, and thus, 1:10 DMSO in saline was used as the vehicle. It is our experience that DMSO infusions, even very dilute solutions, can elicit dilator responses in the coronary circulation; therefore, a second set of swine (n = 5) received intracoronary infusions of this vehicle only. Data are presented as a change in flow relative to the baseline within a group (vehicle vs. correolide). Vehicle infusions rates were matched to those necessary for correolide. Vehicle alone significantly increased coronary blood flow (0.18 ± 0.07 ml/min/g; n = 5) at the infusion rates needed to approach concentrations of 1 and 3 lM correolide (Fig. 5) . The initial vehicle studies with infusion rates necessary to obtain coronary plasma concentrations of 10 lM correolide increased baseline coronary blood flow [ 2-fold. Thus, we were unable to fluorescence across a section of myocardium stained with K V 1.5 antibody pre-adsorbed to its antigenic peptide (e; the green and blue channels are shown in f). Note the lack of green immunofluorescence in the red peaks. g Line scans of the intensity of green (K V 1.5) and red (SMA) fluorescence across a section of heart incubated without the primary K V 1.5 antibody (h; the green and blue channels are shown in i). Note the lack of green immunofluorescence perform in vivo studies with concentrations of correolide exceeding 3 lM. In contrast to vehicle administration, intracoronary infusion of correolide concentration-dependently decreased coronary blood flow (-0.12 ± 0.03 ml/min/g; Fig. 5 ). Correolide administration significantly reduced coronary blood flow *25 % (i.e., reduced from *1.0 to 0.72 ml/min/g with 3 lM correolide; P = 0.01). Because DMSO increased flow and is the vehicle for correolide, our experiment likely underestimates the vasoconstriction caused by inhibition of K V 1 channels. A caveat for the experiment, however, is that coronary blood flow decreased, as we infused correolide at a constant rate, and hence, the target concentration in coronary plasma was exceeded. To determine the degree to which the target and actual plasma concentrations differed, we recalculated and determined that reduced coronary plasma flow raised the effective plasma concentrations of correolide to 0.32 ± 0.01, 1.01 ± 0.03, 3.27 ± 0.10 lM. Coronary blood flow data in Fig. 5 are plotted against these calculated correolide concentrations. Despite changes in coronary blood flow relative to MVO 2 (Fig. 5) , neither vehicle nor correolide infusion significantly altered coronary venous PO 2 when myocardial oxygen demand was at a resting level (P = 0.16). 
Role of K V 1 channels in metabolic vasodilation
Our second in vivo experiment was designed to determine the contribution of K V 1 channels to coronary vasodilation in response to increases in myocardial metabolism (e.g., the functional hyperemia that accompanies an increase in heart rate). Hemodynamic data in response to dobutamine (0.3-10 lg/kg/min, iv) in the absence and presence of intracoronary correolide administration (3 lM in coronary plasma) are presented in Table 2 . Dobutamine dose-dependently increased systolic blood pressure and heart rate in vehicle-treated swine (n = 4; a technical problem with blood samples prevented calculation of myocardial oxygen consumption in 1 of the 5 animals intended for this group). Dobutamine increased heart rate, systolic, diastolic, and mean blood pressure in correolide-treated swine (n = 5), however, blood pressures were significantly lower than the vehicle only group (despite randomization of subjects obtained from a common vendor). Regardless of the differences in blood pressure, the dobutamine-induced increase myocardial oxygen consumption was not different in vehicle-vs. correolide-treated swine (49 ± 8-63 ± 9 vs. 44 ± 7-73 ± 7 ll O 2 /min/g; P = 0.97). This is likely due to the fact that heart rate is a more important determinant of myocardial oxygen consumption than afterload [10] . The effect of K V 1-channel inhibition on metabolic coronary vasodilation was examined by analyzing the relationship between coronary blood flow and myocardial oxygen consumption (Fig. 6a) . Linear regression determined that the slope of this relationship was not different in the vehicle and correolide groups (P = 0.34). ANCOVA revealed that correolide markedly reduced coronary blood flow relative to myocardial oxygen consumption across the dobutamine concentration range (P \ 0.001; i.e., correolide shifts the relationship down in a parallel manner). Examining coronary venous PO 2 revealed interesting effects of correolide on the balance between myocardial oxygen supply and demand (Fig. 6b) . In the vehicle only group, coronary venous PO 2 declined, as myocardial oxygen consumption increased. In contrast, in the correolidetreated group, coronary venous PO 2 was lower at rest and did not decline further, as myocardial oxygen consumption increased (P \ 0.05).
K V 1 channels function in ischemic vasodilation
Our final in vivo experiment was designed to determine whether K V 1 channels play a role in coronary reactive hyperemia (i.e., vasodilation in response to a transient myocardial ischemia). Hyperemic responses were elicited by occluding the arterial perfusion cannula for 15 s. Coronary blood flow responses were measured under control conditions (in swine treated with vehicle only; n = 5) and during infusion of correolide at a plasma concentration of 3 lM (n = 5 different swine). Average reactive hyperemia responses are shown in Fig. 7 . Correolide reduced baseline coronary blood flow by *25 % (1.06 ± 0.28-0.79 ± 0.19 ml/min/g; P \ 0.05). Inhibition of K V 1 channels did not affect peak hyperemia (*3.5 ml/min/g; P = 0.29), but correolide significantly decreased the overall volume of repayment by *35 % (1.86 ± 0.39-1.21 ± 0.28 ml/g; P \ 0.05). The study contained ten swine (five each in the correolide-and vehicle-treated groups); however, in this experiment (Table 2 ; Fig. 6 ), a technical problem in measuring MVO 2 reduced the number of observations in the vehicle only group to n = 4 a Difference from baseline within a group (i.e., a significant effect of dobutamine)
Discussion
We used an integrative and complementary set of in vitro and in vivo approaches to evaluate the role of K V 1 channels in the regulation of coronary blood flow in swine. We tested the hypothesis that K V 1 channels are functionally expressed in coronary smooth muscle and regulate coronary vascular tone at rest, in response to increases in myocardial metabolism, and following transient ischemic episodes (reactive hyperemia). All eight known KCNA transcripts were expressed in swine coronary arteries, with KCNA5 (encoding K V 1.5) being most abundant. Immunohistochemistry experiments showed that K V 1.5-channel protein was expressed in the medial (smooth muscle) layer of human and swine coronary arteries-including resistance vessels, which regulate flow. In porcine coronary smooth muscle, the K V 1-selective inhibitor correolide blocked the majority of K ? current, a The relationship between coronary blood flow and myocardial oxygen consumption. Results are from n = 4 pigs in the vehicle group (5 pigs were tested, but all coronary venous blood samples from 1 pig were not collected due to a technical problem) and n = 5 pigs in the correolide-treated group. The rate of myocardial oxygen consumption was increased by infusing dobutamine at four increasing dose rates (Table 2 ). In vehicle-treated pigs, coronary blood flow increased linearly with the rate of myocardial oxygen consumption (filled symbols, solid line). In correolide-treated pigs (3 lM; open symbols, dashed line), the relationship between coronary blood flow and myocardial oxygen consumption was shifted down in a parallel manner (P \ 0.001). b The relationship between coronary venous PO 2 and myocardial oxygen consumption. In the vehicle group, coronary venous PO 2 fell, as myocardial oxygen consumption increased. In the correolide-treated group, coronary venous PO 2 was lower at rest and did not fall further as myocardial oxygen consumption increased. The regression lines are not parallel and different (P \ 0.01) demonstrating that K V 1 subunits are functionally expressed in abundance. K V 1 channels maintain baseline coronary vasomotor tone, as selective inhibition of these channels with correolide reduced coronary blood flow *25 % at the resting heart rate. Correolide significantly depressed the relationship between coronary blood flow and myocardial oxygen consumption, indicating that K V 1 channels may participate in functional hyperemia. K V 1 channels may also function in ischemic dilation, as correolide reduced the overall volume of flow repayment in response to a 15 s coronary occlusion (i.e., K V 1 channels regulate the duration of coronary reactive hyperemia). Alternative interpretations could be that K V 1 channels have a tonic role in the regulation of coronary vascular tone and that inhibiting them results in a parallel shift in the relationship between coronary blood flow and cardiac metabolism and no impairment in peak ischemic vasodilation. These findings support the idea that K V 1 channels are important end-effectors regulating coronary microvascular resistance.
Molecular and functional expression of K V 1 channels in coronary arteries
KCNA gene and K V 1 channel expression in swine coronary arteries confirm and extend prior studies demonstrating the presence of multiple KCNA transcripts and K V 1-channel proteins in coronary arteries from mice, rats, dogs, and swine [3, 9, 13, 30, 31] . The expression of other K Vchannel isoforms (e.g., K V 3 and K V 7 families) has also been documented in coronary arteries of mice, rats, and swine [3, 15, 19, 20, 23, 24] . Correolide blocked a majority of the K ? current in smooth muscle cells; therefore, it is reasonable to conclude that channels composed of K V 1-channel subunits produce a significant portion of the delayed rectifier K ? current. The substantial inhibitory effect of correolide agrees well with what we observed previously in canine coronary smooth muscle cells [9] . Further, the delayed rectifier K ? currents of smooth muscle cells from the coronary arteries of dogs, pigs, and humans have many biophysical and pharmacological similarities [9, 14] , suggesting that K V 1 subunits form at least a portion of the channels. This idea is supported by the detection of K V 1.5 protein expression in the coronary smooth muscle of swine and humans, including resistance vessels.
Role of K V 1 channels in metabolic coronary vasodilation
Identifying the mechanisms coupling coronary blood flow to myocardial metabolism has been a central quest in coronary physiology for over 50 years. There is a growing body of evidence supporting K V channels as critical modulators in the local metabolic control of coronary blood flow [3, 31, 36] . Other K ? channels, such as inwardly rectifying K ? channels (Kir), may also be important [11] , but were not studied here. Non-selective inhibition of K V channels with 4-AP dose-dependently reduces resting coronary blood flow and decreases the balance between myocardial oxygen delivery and metabolism in response to cardiac pacing, norepinephrine, and exercise [3, 36] . Data from this study may support a role for K V 1 channels in coronary metabolic vasodilation [31] , but the mostly parallel downward shift in the relationship between coronary blood flow and myocardial oxygen consumption caused by correolide may be indicative of a tonic role. Intuitively, one would expect a similar parallel downward shift in the relationship between coronary venous PO 2 and myocardial oxygen consumption; however, no such shift was detectable statistically. This may be due to the factors, such as the elevated coronary venous PO 2 typically observed in cannulated preparations and the effect of DMSO to elicit coronary vasodilation. The role of K V 1 channels in regulating the balance between coronary flow and myocardial metabolism is supported by the modest reduction in coronary venous PO 2 at lower levels of myocardial demand (Fig. 6b) . Coronary venous PO 2 was higher in vehicle-treated animals relative to correolide-treated counterparts at the lowest infusion rates (42 ± 4 vs. 35 ± 2 mmHg). This vehicle-induced overperfusion became less significant with increasing metabolic demand. However, owing to lower coronary venous PO 2 values relative to myocardial oxygen consumption at low infusion rates, the slope of the relationship is much flatter in correolide-treated animals than is found in the vehicle only controls (Fig. 6b) .
A recent study demonstrated a much more profound reduction in the slope of the relationship between coronary flow and cardiac double product (index of myocardial metabolism) in K V 1.5 knockout mice during norepinephrine administration [31] . Importantly, this phenotype was associated with significant myocardial hypoxia and was rescued by smooth muscle-specific expression of K V 1.5 in the global knockouts. It should be recognized that while the knockout mouse model provides compelling evidence with genetic targeting of specific channels, compensatory upregulation of other K V channel subtypes and marked differences in the underlying cardiovascular phenotype of mice (heart rate [500 beats/min; coronary blood flow [10 fold higher than large animal models or humans) must be considered. We were unable to use higher concentrations of correolide in vivo to further investigate coronary metabolic vasodilation, as effects of vehicle made higher dose rates of impractical. Together, these findings collectively support a prominent role for K V 1 channels as crucial end-effectors in the coronary circulation of mice, dogs, and swine.
We did not focus on identifying specific factors that converge on K V 1 channels in this investigation. However, prior studies have demonstrated that putative dilators, such as adenosine, nitric oxide, prostacyclin, and H 2 O 2 mediate coronary vasodilation, at least in part, via 4-AP-sensitive K V channels. Our prior study also established that correolide significantly reduces dilation of isolated coronary arterioles to adenosine and sodium nitroprusside [9] , indicating that K V 1 channels are the targets of known coronary vasodilators. There are likely numerous endothelial and metabolic factors that converge on K V 1 channel subtypes to modulate coronary vascular tone, including H 2 O 2 [34] [35] [36] . Alternatively, it is well established that direct badrenoceptor activation contributes to the control of coronary blood flow during increases in myocardial metabolism [29] . Thus, it is possible that increases in coronary flow in response to catecholamine administration (or elevated sympathetic tone and plasma catecholamine concentrations with exercise) induce smooth muscle relaxation via a cAMP-protein kinase-dependent activation of K V 1 channels [1, 2] . Numerous additional studies will be needed to examine the precise K V -channel subtypes responsible for eliciting dilation to these, as well as other, putative factors.
Role of K V 1 channels in ischemic coronary vasodilation
Coronary dilation in response to myocardial ischemia is a critical mechanism that sustains oxygen delivery to the heart to mitigate ischemic injury and infarction. A wellaccepted experimental approach to examine ischemic coronary vasodilation is to measure coronary blood flow responses following a brief coronary artery occlusion. This reactive hyperemia has been attributed to a variety of mechanisms, including myogenic, endothelial, and local metabolic factors [38] . Prior work from our laboratory supports relatively modest roles for adenosine and nitric oxide, with a more pronounced contribution of K V and K ATP channels [5, 9] . The extent to which K V 1 channels contribute to coronary reactive hyperemia, however, has not previously been investigated.
Inhibition of K V 1 channels with correolide significantly decreased overall repayment of flow debt. This suggests that factors produced during acute myocardial ischemia elicit vasodilation, in part, via K V 1 channels. This overall effect of correolide is similar to our earlier findings in dogs with 4-AP, which diminished baseline flow and the overall volume of repayment [9] . In contrast, we recently documented that inhibition of K V 7 channels with linopirdine had no effect on coronary reactive hyperemic responses in swine [15] . Although correolide diminished the duration of reactive hyperemia, it is important to point out that peak hyperemia was unaffected by the correolide, which could be interpreted as no role for K V 1 channels. Peak responses increase with the duration of the occlusion up to *15-30 s, indicating that maximal vasodilator capacity is reached within 30 s of ischemia. Thus, one could conclude that K V 1 channels do not contribute to ischemic coronary vasodilation. However, we argue that the reduction in volume of repayment (duration of ischemic vasodilation) supports a role for these channels, as the hyperemic response is estimated to provide only *80 % of the necessary oxygen repayment incurred during the flow deficit.
Implications and conclusions
K V 1 channels are functionally expressed and contribute to the regulation of coronary microvascular resistance at rest, during b-adrenoceptor activation, and myocardial ischemia. We propose that K V 1.5 channels are likely to be the predominant subtype; however, the lack of specific pharmacologic agents to activate or inhibit K V 1.5 channels currently prevents direct examination of this hypothesis in our large animal preparation. While these studies were performed in normal healthy swine, prior evidence from our laboratory [3] and others [25, 26, 28] indicates that K Vchannel function is impaired by obesity and/or diabetes mellitus. Furthermore, coronary microvascular dysfunction has been linked with several other pathologic conditions, including hypertension, Takotsubo cardiomyopathy, heart failure with preserved ejection fraction, and no re-flow phenomenon [6, 32, 33] . Thus, further examination of the role of coronary K V 1 channels is likely to provide much needed insight into physiologic and pathophysiologic mechanisms of coronary flow regulation.
